-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Initiates Coverage On Palvella Therapeutics with Buy Rating, Announces Price Target of $175

Benzinga·12/04/2025 17:52:59
Listen to the news
Craig-Hallum analyst Albert Lowe initiates coverage on Palvella Therapeutics (NASDAQ:PVLA) with a Buy rating and announces Price Target of $175.